Spotlab

What Spotlab does

SpotLab is a Madrid-based clinical AI company founded in 2018 as a spin-off of Universidad Politécnica de Madrid, developing AI models for medical diagnostics and biopharma research. Its core technology is the TeleSpot platform, a multi-modal digitalization and AI system combining cloud architecture with web and smartphone apps, proprietary foundational AI models for in-vitro image analysis (ViT transformer architectures), and LLMs/LMMs for clinical decision support. The product portfolio includes MedulAI for bone marrow cell classification (23 subtypes, trained on 500,000+ cells from 1,000+ patients), ParasitAI for parasite quantification (>90% accuracy across 11 parasites, 100,000+ training images), MultiplexAI for multiplex microscopy diagnosis, Florence as an LMM-based skin NTD copilot, plus supporting tools (Ada, TiraSpot, RetiSpot, HuggingSpot) and 3D-printed smartphone adapters enabling offline edge-AI deployment.

The company serves three primary customer segments: hospitals and healthcare providers (including Hospital 12 de Octubre, Hospital Vall d'Hebron, Hospital Clínico San Carlos), biopharma companies and research centers (including GSK and a top-10 global pharmaceutical company), and global health organizations and NGOs (including DNDi, FIND, ISGlobal, KEMRI, and ISCIII). Revenue is generated through custom AI model development services, platform licensing and API deployment, and certified IVD medical device software sales. Distribution is sales-led with direct enterprise engagement and API integration; pricing is not publicly disclosed.

SpotLab has achieved CE marking for IVD software and AEMPS certification for two products, with ISO-13485, IVDR, and GDPR compliance. The company operates across 14+ countries spanning Europe, Africa, Latin America, and Asia, with significant non-dilutive funding from the Bill & Melinda Gates Foundation, the European Union (H2020, EDCTP3, NextGenerationEU), CDTI, and Comunidad de Madrid. As a 20+ employee company operating in a deeptech niche, SpotLab combines academic research roots with a grant-funded, partnership-heavy growth model targeting both high-income hospital markets and resource-constrained global health settings.

Name

Spotlab

Legal name

SPOTLAB, S.L.

Website

https://spotlab.ai

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

SpotLab is a Madrid-based clinical AI company building foundational AI models and the TeleSpot platform for medical diagnostics (hematology, parasitology, skin NTDs) and biopharma research, serving hospitals, global health NGOs, and pharmaceutical companies across 14+ countries.

Ownership category

akta.pro rank

Product category

Medical Diagnostic AI Software

NAICS

Medical Laboratories (621511), Diagnostic Imaging Centers (621512)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Medical diagnostic AI
• Clinical research AI
• Pathology image analysis
• Hematology AI software
• Parasitology detection AI

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. AI Services for Biopharma and Research Centers: Custom AI model development and validation services for biopharma companies and research centers. Includes predictive models for adverse events, diagnostic algorithms, and treatment response models developed in collaboration with pharmaceutical partners and hospitals.
2. AI Platform Licensing and Deployment: Platform deployment options including cloud access, API integration, and edge-AI solutions. Revenue from licensing technology and providing end-to-end or modular AI solutions.
3. Medical Device Software (IVD): AI-powered diagnostic software as medical devices. Two products certified by AEMPS (Spanish Agency for Medicines and Health Products) for clinical use.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

SpotLab develops AI diagnostic models and the TeleSpot platform for clinical research and medical diagnosis. Its product portfolio includes MedulAI (bone marrow cell analysis classifying 23 cellular subtypes), ParasitAI (parasite quantification across 11 parasites with >90% accuracy), MultiplexAI (multiplex disease detection from microscope slides via smartphone-connected 3D-printed adapters), and Florence (multimodal AI copilot for skin neglected tropical diseases). Solutions are deployed via cloud, API, and edge-AI on mobile devices for use in hospitals, research centers, and resource-constrained settings.

Product overview

SpotLab is an AI model factory for medical diagnostics and biopharma research, offering a unified platform architecture centered on the TeleSpot platform. TeleSpot provides the core infrastructure connecting cloud and edge AI with web/smartphone applications for clinical deployment. The product portfolio includes two flagship AI diagnostic products: MedulAI for bone marrow cell analysis in hematology (23 subtypes, 500K+ cells trained), and ParasitAI for parasite quantification in microscopy (11 parasites, 90%+ accuracy). MultiplexAI transforms any microscope into an AI copilot for multiplexed disease detection. Supporting products include Florence (multimodal AI assistant for skin NTDs), Ada (hematology AI assistant), TiraSpot (rapid test reader), RetiSpot (fundus imaging), HuggingSpot (model distribution app), and hardware adapters AdaptaSpot and MicraSpot. Services include custom AI development, predictive modeling, and professional training workshops.

Differentiator

Problem solved

Functional benefit

Brands

• MedulAI: AI model for supporting cell counting and analysis in bone marrow samples, capable of classifying among 23 cellular subtypes based on training dataset of +500,000 cells from +1000 patients.
• ParasitAI
• TeleSpot
• MultiplexAI
• Florence
• Ada
• HuggingSpot
• RetiSpot
• TiraSpot

Products and services

• TeleSpot Proprietary multi-modal digitalization and AI platform ecosystem to create and deploy AI models in clinical environments. Composed of cloud architecture connected with web and smartphone apps, smartphone-based digitalization devices, and proprietary foundational AI models for in-vitro image analysis.
• MedulAI AI model designed to support cell counting and analysis in bone marrow samples, classifying among 23 cellular subtypes based on training dataset of 500,000+ cells from 1,000+ patients. Automates differential cell counting for blood cancer diagnosis in hematology departments.
• ParasitAI Foundational AI model for rapid autonomous quantification of different parasites in microscope smears with >90% accuracy across 11 parasites including filarial species causing filariasis and Plasmodium species causing malaria. Trained on 100,000+ images.
• MultiplexAI AI mobile diagnostic copilot that transforms conventional microscopes into smart devices capable of detecting every disease visible on a microscopy slide. Works offline on smartphones connected via 3D-printed adapters; built as part of an Africa-Europe consortium.
• Florence Smartphone copilot based on Large Multimodal Models (LMMs) for diagnosis, management and follow-up of patients with suspected skin Neglected Tropical Diseases (NTDs) such as Buruli ulcer, leprosy, yaws and scabies. Developed in collaboration with WHO guidelines.
• Ada AI assistant integrated into case management platform to support hematologists with clinical decision-making and patient data analysis.
• TiraSpot Universal AI algorithm capable of interpreting any rapid test with up to three bands, sending results to a monitoring platform for epidemic surveillance.
• RetiSpot Portable, 3D-printed, smartphone-controlled retinograph connected to telemedicine web platform for screening fundus lesions, developed for ophthalmology diagnostics.
• HuggingSpot Mobile application available on Google Play Store enabling the scientific community to download and test SpotLab's AI models for microfilariae detection and filarial species differentiation.
• AI Services Custom AI model development and validation services for biopharma companies and research centers. Includes predictive models for adverse events, diagnostic algorithms, and treatment response models developed in collaboration with pharmaceutical partners and hospitals.
• AI Workshops and Challenges AI workshops and diagnostic competitions for professional training and scientific dissemination in healthcare and tropical medicine.

Quantifiable outcome

• >90% accuracy across 11 parasites
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability16 records

Feature6 records

Partnerships

23 partnerships are on record, tiered core and supporting.

• ISGlobal (Barcelona Institute for Global Health)coreStrategic or Co-development Partner · 19 September 2025MultiplexAI consortium coordination for developing AI diagnostic copilot for parasitic diseases. ISGlobal coordinates 9-institution Africa-Europe partnership with €5M EDCTP3 funding.
• Ahmadu Bello University (Nigeria)coreStrategic or Co-development PartnerMultiplexAI consortium partner for clinical validation of AI diagnostic technology in Nigeria.
• Fundação Manhiça (Mozambique)coreStrategic or Co-development PartnerMultiplexAI consortium partner conducting clinical studies for parasitic disease diagnosis in Mozambique.
• Université Félix Houphouët-Boigny (Ivory Coast)coreStrategic or Co-development PartnerMultiplexAI consortium partner for African clinical validation sites.
• Jimma University (Ethiopia)coreStrategic or Co-development PartnerMultiplexAI consortium partner for field validation in Ethiopia.
• IRCCS Ospedale Sacro Cuore Don Calabria (Italy)coreStrategic or Co-development PartnerMultiplexAI consortium partner contributing European clinical expertise.
• Hutzpa Innovations (Nigeria)supportingStrategic or Co-development PartnerMultiplexAI consortium partner providing innovation consultancy.
• Hospital 12 de OctubrecoreStrategic or Co-development PartnerALMA project partner for AI development for leukemia diagnosis and prognosis. Development of bone marrow analysis AI models.
• Hospital Vall d'HebroncoreStrategic or Co-development PartnerALMA project partner for hematopoietic disorder characterization and bone marrow image analysis research.
• Hospital Clínico San CarloscoreStrategic or Co-development PartnerALMA project partner for MDS diagnostic and prognostic AI algorithms development.
• Universidad Politécnica de Madrid (UPM)coreStrategic or Co-development PartnerSpin-off origin. ALMA project partner with CIBER-BBN collaboration. Ongoing research partnership for AI and biomedical applications.
• Universidad Complutense de Madrid (UCM)coreStrategic or Co-development PartnerALMA project consortium partner for hematological disease AI research.
• GSKcoreStrategic or Co-development PartnerInnovation program for digital transformation of hematology departments across 10+ Spanish hospitals.
• Kenya Medical Research Institute (KEMRI)coreStrategic or Co-development PartnerCollaboration on helminth egg identification (Trichuris trichiura, Ascaris lumbricoides, hookworms) in stool samples for soil-transmitted helminthiasis.
• Instituto de Salud Carlos III (ISCIII)coreStrategic or Co-development PartnerMultiple collaborations including filariasis detection, Cryptococcus quantification, ALMA project, and Florence AI assistant development. CNM-ISCIII provides clinical validation.
• DNDicoreStrategic or Co-development PartnerCollaboration for digital tools supporting visceral leishmaniasis treatment development including AI for diagnostic quantification.
• FINDcoreStrategic or Co-development PartnerCollaboration for diagnostic support in visceral leishmaniasis and evaluation of rapid tests for Chagas disease in endemic countries.
• University of California, BerkeleysupportingStrategic or Co-development PartnerCollaboration for schistosomiasis egg quantification in stool or urine samples.
• Universidad Mayor de San Simón (Bolivia)supportingStrategic or Co-development PartnerBlood parasite detection AI collaboration for malaria, Chagas disease, leishmaniasis, and filariasis.
• Oswaldo Cruz Foundation - Fiocruz (Brazil)supportingStrategic or Co-development PartnerBlood parasite detection AI collaboration for parasitic diseases diagnosis.
• Institute for Medical Research (IMR, Malaysia)supportingStrategic or Co-development PartnerBlood parasite detection AI collaboration for regional parasitic disease research.
• Fundación Mundo Sano (Argentina)supportingStrategic or Co-development PartnerBlood parasite detection AI collaboration for Chagas disease and other parasitic diseases.
• Hardian HealthsupportingImplementation/ SI/ Consulting PartnerRegulatory consultancy partnership for CE marking and IVD regulation navigation to achieve approval for in vitro diagnostic device software.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Emerging players

• SigTuple: SigTuple applies AI to digital microscopy for blood analysis and other diagnostics, with focus on emerging markets — closely aligned with SpotLab's MedulAI/ParasitAI cell and parasite quantification on microscopy images.
• Aignostics: Aignostics offers AI for pathology image analysis with a focus on biopharma clients and explainable models — directly comparable to SpotLab's biopharma-custom-AI revenue stream and microscopy-based diagnostic IP.
• Qure.ai: Qure.ai builds AI for medical imaging interpretation (notably chest X-ray, head CT, and tuberculosis) with deployments in resource-limited settings — closely comparable to SpotLab's MultiplexAI mission of bringing AI diagnostics to underserved geographies.

Direct peers

• Ibex Medical Analytics: Ibex develops AI for cancer pathology diagnostics deployed in hospital pathology workflows — comparable to SpotLab's histopathology-adjacent MedulAI and its broader 'AI diagnostic-aid for hospital labs' positioning.
• Paige.AI: Paige develops AI for pathology and oncology image analysis, including FDA-cleared products — directly comparable to SpotLab's microscopy-AI diagnostic approach targeting cancer and hematological disease workflows.
• Scopio Labs: Scopio Labs builds AI-powered digital microscopy platforms for hematology and cell morphology analysis — directly overlapping with SpotLab's MedulAI bone-marrow cell counting and classification use case targeting hospital hematology labs.
• PathAI: PathAI provides AI-powered pathology diagnostics for hospitals and biopharma, including tissue-based disease detection and biomarker quantification — directly comparable to SpotLab's microscopy-based AI diagnostics and biopharma service offerings.

Broad incumbents

• Owkin: Owkin is a federated-learning AI platform serving biopharma R&D and hospital diagnostics across multiple disease areas — comparable to SpotLab's biopharma AI services and multi-disease diagnostic portfolio at a larger scale.
• Tempus Labs: Tempus is a large AI-driven precision medicine company combining molecular data, imaging, and clinical records for diagnostics and biopharma — overlapping with SpotLab's predictive modeling, imaging AI, and biopharma service offerings.
• Lunit: Lunit provides AI-powered medical imaging analysis (notably mammography and chest imaging) with global hospital deployments — comparable to SpotLab's clinical imaging AI business model and global commercial footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/Spotlab__
• LinkedInlinkedin.com/company/spotlabinternational
• Instagraminstagram.com/spotlab_team

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spotlab